← CHEMED CORP CHE
Market Price
$533.47
Market Cap
$7.10B
P/E Ratio
29.09
Revenue (FY 2025)
↑61.5% YoY
$2.53B
3-Yr CAGR: 27.1%
Net Income
↓-12.2% YoY
$265.24M
Net Margin: 10.5%
Free Cash Flow
↓-11.5% YoY
$325.48M
FCF Yield: 4.58%
EPS (Diluted)
↓-7.8% YoY
$18.34
Basic: $18.42
Return on Equity
Efficiency
27.1%
ROA: 87.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CHE)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,576.9M | — | $461.4M | $108.7M | — | $6.48 | — | $135.4M | $95.6M | — |
| FY 2017 | $1,666.7M | +5.7% | $516.2M | $98.2M | -9.7% | $5.86 | -9.6% | $162.5M | $98.2M | +2.7% |
| FY 2018 | $1,223.5M | -26.6% | $-31.1M | $205.5M | +109.4% | $12.23 | +108.7% | $287.1M | $234.3M | +138.6% |
| FY 2019 | $1,319.9M | +7.9% | $-39.9M | $219.9M | +7.0% | $13.31 | +8.8% | $301.2M | $248.2M | +6.0% |
| FY 2020 | $1,368.5M | +3.7% | $-43.5M | $319.5M | +45.3% | $19.48 | +46.4% | $489.3M | $430.5M | +73.4% |
| FY 2021 | $1,289.4M | -5.8% | $-108.2M | $268.6M | -15.9% | $16.85 | -13.5% | $308.6M | $249.9M | -41.9% |
| FY 2022 | $1,231.0M | -4.5% | $-168.3M | $249.6M | -7.0% | $16.53 | -1.9% | $309.9M | $252.6M | +1.1% |
| FY 2023 | $1,348.1M | +9.5% | $-150.5M | $272.5M | +9.2% | $17.93 | +8.5% | $330.3M | $273.4M | +8.3% |
| FY 2024 | $1,566.3M | +16.2% | $-46.0M | $302.0M | +10.8% | $19.89 | +10.9% | $417.5M | $368.0M | +34.6% |
| FY 2025 | $2,530.0M | +61.5% | $823.2M | $265.2M | -12.2% | $18.34 | -7.8% | $388.3M | $325.5M | -11.5% |
Valuation
Market Price
$533.47
Market Cap
$7.10B
Enterprise Value
N/A
P/E Ratio
29.09
P/B Ratio
7.20
FCF Yield
4.58%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
32.54%
Operating Margin
13.37%
Net Margin
10.48%
Return on Equity (ROE)
27.08%
Return on Assets (ROA)
87.65%
Asset Turnover
8.36x
Revenue 3-Yr CAGR
27.14%
Financial Health & Liquidity
Current Ratio
1.05
Cash Ratio
0.26
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$74.52M
Total Debt
N/A
Book Value / Share
$74.09
Cash Flow Efficiency
Operating Cash Flow
$388.27M
Capital Expenditures (CapEx)
$62.80M
Free Cash Flow
$325.48M
OCF / Revenue
15.35%
FCF / Revenue
12.86%
FCF 3-Yr CAGR
8.82%
Per Share Metrics
EPS (Diluted)
$18.34
EPS (Basic)
$18.42
Dividends / Share
N/A
Book Value / Share
$74.09
EPS YoY Growth
-7.79%
Balance Sheet (FY 2025)
Total Assets
$302.62M
Total Liabilities
$287.13M
Stockholders' Equity
$979.40M
Current Assets
$302.62M
Current Liabilities
$287.13M